Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126455) titled 'Dynamic Proteomic Alterations in NF1-Associated Plexiform Neurofibromas During Luvometinib Treatment: An Observational Study' on June 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shandong Provincial Hospital
Condition:
Neurofibromatosis type 1 (NF1)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-15
Target Sample Size: Luvometinib:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324068
Published by HT Digital Content Services with permission from Health Daily Digest....